Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-04-03
1976-02-10
Ore, Dale R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
A61K 2902
Patent
active
039378004
ABSTRACT:
An X-ray contrast method containing as the essential radioopaque ingredient finely divided tantalum metal dispersed in a liquid vehicle having critical viscosity and flow properties. The metal has an average particle diameter in the range from about 0.5 to about 30 microns, and preferably in the range from about 1 to about 5 microns in a physiologically and pharmaceutically acceptable amount for use in obtaining X-ray films of sufficient clarity and detail for use in bronchography.
REFERENCES:
patent: 1918884 (1933-07-01), Zellmann et al.
patent: 2387704 (1945-10-01), McLachlan, Jr.
Nadel et al., Investigative Radiology, July-Aug. 1968, Vol. 3, pp. 229 to 238.
Chem. Abs., 1942, Vol. 38, p. 6191.
Chem. Abs., 1953, p. 12026.
Chem. Abs., 1952, Vol. 48, p. 5589.
Chem. Abs., 1958, Vol. 46, p. 5959.
Dure-Smith Peter
Schnaare Roger L.
Marlino Joseph A.
Ore Dale R.
LandOfFree
Bronchographic X-ray contrast method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bronchographic X-ray contrast method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bronchographic X-ray contrast method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-150288